# Editorial: Reviews in experimental pharmacology and drug discovery 2023: pharmacological management of non-communicable diseases

**Authors:** Ali Sharif, Virginia Flores-Morales, Hanan Farouk Aly

PMC · DOI: 10.3389/fphar.2025.1435638 · Frontiers in Pharmacology · 2025-04-01

## Full-text entities

- **Diseases:** stones (MESH:D007669), CRBD (MESH:D055499), attention-deficit hyperactive syndrome (MESH:D001289), ureteral stones (MESH:D014515), morning sickness (MESH:D048968), hyperglycemia (MESH:D006943), diabetes mellitus (MESH:D003920), nausea and vomiting (MESH:D020250), -communicable (MESH:D003141), cancer (MESH:D009369)
- **Chemicals:** Nefopam (MESH:D009340), Ondansetron (MESH:D017294), Amphetamine (MESH:D000661), mirabegron (MESH:C520025)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11996782/full.md

---
Source: https://tomesphere.com/paper/PMC11996782